Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy

Type 1 Diabetes

Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance

Front Endocrinol (Lausanne)

Lambadiari V, Kountouri A, Maratou E, Liatis S, Dimitriadis GD, Karpe F

doi: 10.3389/fendo.2021.684182

Obesity and Bariatric Surgery

The Potential Role of Combination Pharmacotherapy to Improve Outcomes of Pediatric Obesity: A Case Report and Discussion

Front Pediatr.

Fox CK, Kelly AS

doi: 10.3389/fped.2018.00361.

Successful treatment of a patient with refractory nephrotic syndrome with PCSK9 inhibitors: a case report

BMC Nephrol.

Awanami Y, Fukuda M, Nonaka Y, Takashima T, Matsumoto K, Yamasaki M, Miyazono M, Ikeda Y

doi: 10.1186/

Type 2 Diabetes

Metformin-associated lactic acidosis precipitated by liraglutide use: adverse effects of aggressive antihyperglycaemic therapy

BMJ Case Rep.

Hooda A, Mehta A, Hannallah F

doi: 10.1136/bcr-2018-227102.

Diabetes - GeneralType 1 DiabetesThyroid

Autoimmune diabetes induced by PD-1 inhibitor-retrospective analysis and pathogenesis: a case report and literature review

Cancer Immunol Immunother.

Gauci ML, Laly P, Vidal-Trecan T, Baroudjian B, Gottlieb J, Madjlessi-Ezra N, Da Meda L, Madelaine-Chambrin I, Bagot M, Basset-Seguin N, Pages C, Mourah S, Boudou P, Lebbé C, Gautier JF

doi: 10.1007/s00262-017-2033-8.

Diabetes - GeneralType 2 Diabetes

Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor

J Emerg Med.

Andrews TJ, Cox RD, Parker C, Kolb J

doi: 10.1016/

Diabetes - General

A case of insulin allergy successfully managed using multihexamer-forming insulin degludec combined with liraglutide

Diabet Med.

Fujishiro M, Izumida Y, Takemiya S, Kuwano Y, Takamoto I, Suzuki R, Yamauchi T, Ueki K, Kadowaki T

doi: 10.1111/dme.12998.

Lipids

Acquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related Diabetes

Diabetes Care.

Jehl A, Cugnet-Anceau C, Vigouroux C, Legeay AL, Dalle S, Harou O, Marchand L, Lascols O, Caussy C, Thivolet C, Laville M, Disse E

doi: 10.2337/dc18-2535.

Diabetes - GeneralGlycemic Control

Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation

J Pediatr Endocrinol Metab.

Yildiz M, Akcay T, Aydin B, Akgun A, Dogan BB, De Franco E, Ellard S, Onal H

doi: 10.1515/jpem-2017-0325.

Related content